ArticleTrials2022

TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.

Catherine Berry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.